Next, we examined the ability of idelalisib, obinutuzumab, or the combination to induce direct cell death in primary CLL cultures stimulated with anti-IgM/IgG/CD40 to mimic prosurvival signaling within the tissues. This evidence concerns the gene CD40LG and B-cell chronic lymphocytic leukemia.